{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:24Z","timestamp":1790899464532,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic and Legal Medicine"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jflm.2013.09.019","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T14:07:22Z","timestamp":1380722842000},"page":"1024-1027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: Role of pharmacogenomics"],"prefix":"10.1016","volume":"20","author":[{"given":"Alan H.B.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jflm.2013.09.019_bib1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jflm.2013.09.019_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03256429","article-title":"Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide","volume":"16","author":"Eissing","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jflm.2013.09.019_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.tpj.6500406","article-title":"Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication","volume":"7","author":"Kirchheiner","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jflm.2013.09.019_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007691-199710000-00010","article-title":"Quantification of the O- and N-demethylated and the glucuroonidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators","volume":"19","author":"Yue","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jflm.2013.09.019_bib5","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"\u03bc receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Cheng","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.jflm.2013.09.019_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2125.1995.tb04428.x","article-title":"Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive and one poor metabolizer of dextromethorphan","volume":"38","author":"Persson","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jflm.2013.09.019_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00008571-199710000-00006","article-title":"Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence","volume":"7","author":"Tyndal","year":"1997","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jflm.2013.09.019_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.1991.tb05550.x","article-title":"Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers","volume":"31","author":"Chen","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jflm.2013.09.019_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2125.1995.tb04428.x","article-title":"Pateit-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metabolizer of dextromethorphan","volume":"39","author":"Persson","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jflm.2013.09.019_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.forsciint.2012.01.019","article-title":"Investigation of morphine and morphine glucuronide levels and cytochrome P450 isoenzyme 2D6 genotype in codeine-related deaths","volume":"220","author":"Frost","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jflm.2013.09.019_bib11","series-title":"Analytical procedures for therapeutic drug monitoring and emergency toxicology","author":"Baselt","year":"1987"},{"key":"10.1016\/j.jflm.2013.09.019_bib12","unstructured":"TIAFT drug reference ranges. www.tiaft.org."},{"key":"10.1016\/j.jflm.2013.09.019_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jflm.2012.10.005","article-title":"Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales","volume":"20","author":"Burch","year":"2013","journal-title":"J\u00a0Foren Legal Med"},{"key":"10.1016\/j.jflm.2013.09.019_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0885-3924(03)00176-3","article-title":"Are opioid-dependent\/tolerant patients impaired in driving related skills? A structured evidence-based review","volume":"25","author":"Fishbain","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jflm.2013.09.019_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11916-008-0007-4","article-title":"Cognitive effects of opioids","volume":"12","author":"Strassels","year":"2008","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jflm.2013.09.019_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00265920","article-title":"The effect of quinidine on the analgesic effect on codeine","volume":"42","author":"Sindrup","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jflm.2013.09.019_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(24)34915-8","article-title":"Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamics effects","volume":"290","author":"Caraco","year":"1999","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jflm.2013.09.019_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00004714-200008000-00008","article-title":"Inhibition of cytochrome P450 2D6 modifies codeine abuse liability","volume":"20","author":"Kathiramalianathan","year":"2000","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jflm.2013.09.019_bib19","unstructured":"Lexi-corp Online Lexi-Interact. Lexicomp Inc. 2013 in UpToDate, Wolters Kluwer Health, Philadelphia, PA."},{"key":"10.1016\/j.jflm.2013.09.019_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jflm.2013.09.019_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00004714-200002000-00008","article-title":"Cytochrome P450 2D and treatment of codeine dependence","volume":"20","author":"Romach","year":"2000","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jflm.2013.09.019_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.jcp.0000162805.46453.e3","article-title":"Inhibition of CYP2D6 activity by bupropion","volume":"25","author":"Kotlyar","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"}],"container-title":["Journal of Forensic and Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X13002588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X13002588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:52Z","timestamp":1761696412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1752928X13002588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1752928X13002588"],"URL":"https:\/\/doi.org\/10.1016\/j.jflm.2013.09.019","relation":{},"ISSN":["1752-928X"],"issn-type":[{"value":"1752-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: Role of pharmacogenomics","name":"articletitle","label":"Article Title"},{"value":"Journal of Forensic and Legal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jflm.2013.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}